Recently, the Shandong Securities Regulatory Bureau issued a decision to issue a warning letter to nine people including Qu Yong. Because Chengdu Yingde Biomedical Equipment Technology Co., Ltd. (hereinafter referred to as Chengdu Yingde) failed to fulfill its performance compensation commitment for Xinhua Medical before the stipulated date, the Shandong Securities Regulatory Bureau adopted a warning sign issuing warning letters to 9 people including Qu Yong and related The situation is recorded in the securities and futures market integrity file.
Not long ago, Xinhua Medical received a letter of supervision from the Shanghai Stock Exchange, and was urged to urge nine performance commitment parties such as Qu Yong to fulfill performance compensation obligations. Xinhua Medical replied on the evening announcement on June 16th that the company had filed a lawsuit with the court on June 2, 2017 to recover the company's rights and interests. This is the second time that Xinhua Medical has brought the responsible person to court because Chengdu Yingde failed to fulfill its performance compensation commitment.
Shandong Xinhua Medical Equipment Co., Ltd.
3 years of unfinished performance commitments total compensation of 226 million Chengdu Yingde old accounts are unclear and tired "new debt"
In 2014, Xinhua Medical purchased 85% of Chengdu Yingde by issuing shares and paying cash. The two parties signed the “Profit Compensation Agreement for Issuing Shares and Paying Cash to Purchase Assetsâ€. According to the agreement, Chengdu Yingde promised that the audited net profit attributable to the parent company after deducting non-recurring gains and losses will not be less than 38 million yuan in 2014, not less than 42.8 million yuan in 2015 and not less than 45.8 million yuan in 2016. In 2017, no less than 46.8 million yuan. If Chengdu Yingde fails to meet the above net profit target as agreed, then nine natural persons such as Quyong will promise to compensate the company in cash. The compensation amount is: (the target net profit for the year (net of non-recurring gains and losses) - actual realization Net profit (net of non-recurring gains and losses)) × 2.
Chengdu Yingde promises Xinhua Medical's performance and actual situation
Judging from the actual operation of Chengdu Yingde, the performance commitments in the agreement have not been fulfilled for three consecutive years after being subscribed by Xinhua Medical. Chengdu Yingde has to pay twice the compensation amount for the poor performance. According to Xinhua Medical Announcement, Chengdu Yingde's 2014 annual performance compensation has been paid in full by nine natural persons such as Qu Yong and in accordance with the agreement, and the performance compensation obligation has been completed. In 2015, the performance compensation was not smooth. As of May 20, 2016, Xinhua Medical received a total of 7,422,500 yuan of performance compensation for Qu Hong and Su Xiaodong, and seven natural persons including Qiu Jiashan failed to fulfill their performance commitment obligations. Xinhua Medical therefore filed a lawsuit in the court and won the case. However, as of June 16 this year, there are still five natural persons, including Qiu Jiashan, who have not fulfilled their payment obligations in accordance with the judgment.
In 2015, the performance compensation has not been paid off. In 2016, Chengdu Yingde, which had its own losses of more than 50 million yuan, must also face a huge performance compensation of 192 million yuan. This time, 9 performance commitment parties such as Quarong said they could not repay. . On June 2 this year, Xinhua Medical also brought nine people to court for the recovery of compensation.
We're Professional Supplier Extract Powder manufacturers and suppliers in China specialized in providing high-quality products at low price. We warmly welcome you to buy or wholesale bulk Supplier Extract Powder for sale here from our factory. For a free sample, contact us now.
Supplier Extract Powder,Supplier Extract ,Supplier Powder Manufacturer in China
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.anabolicsteriod.com